TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+7.62%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(-8.4%)
Cap. Flow
-$39.8M
Cap. Flow
% of AUM
-12.49%
Top 10 Holdings %
Top 10 Hldgs %
61.39%
Holding
40
New
6
Increased
8
Reduced
13
Closed
6
Top Buys
| 1 |
Medtronic
MDT
|
$10.4M |
| 2 |
AdaptHealth
AHCO
|
$6.65M |
| 3 |
Turning Point Brands
TPB
|
$5.72M |
| 4 |
Plexus
PLXS
|
$5.58M |
| 5 |
AtriCure
ATRC
|
$4.99M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
$20M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$11M |
| 3 |
UnitedHealth
UNH
|
$10.3M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
$7.73M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
$7.47M |
Sector Composition
| 1 | Healthcare | 91.35% |
| 2 | Technology | 6.86% |
| 3 | Consumer Staples | 1.79% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pacira BioSciences
PCRX
$1.2B
| $39.4M | 12.14% |
655,000
-45,000
| -6% | -$2.71M |
|
|
2
Medtronic
MDT
$119B
| $26M | 8.01% |
250,000
+100,000
| +67% | +$10.4M |
|
3
Hologic
HOLX
$14.9B
| $19.9M | 6.15% |
300,000
-25,000
| -8% | -$1.66M |
|
4
Perrigo
PRGO
$3.27B
| $19.7M | 6.08% |
430,000
-45,000
| -9% | -$2.07M |
|
5
Rigel Pharmaceuticals
RIGL
$697M
| $18M | 5.55% |
7,500,000
+650,000
| +9% | +$1.56M |
|
6
United Therapeutics
UTHR
$13.8B
| $16.2M | 4.98% |
160,000
-15,000
| -9% | -$1.52M |
|
|
MDRX
7
DELISTED
Veradigm Inc. Common Stock
MDRX
| $15.5M | 4.77% |
1,900,000
+300,000
| +19% | +$2.44M |
|
8
Labcorp
LH
$23.1B
| $15.1M | 4.64% |
80,000
+25,000
| +45% | +$4.71M |
|
|
9
AtriCure
ATRC
$1.84B
| $14M | 4.3% |
350,000
+125,000
| +56% | +$4.99M |
|
10
Lantheus
LNTH
$3.73B
| $12M | 3.71% |
950,000
| – | – |
|
|
NUAN
11
DELISTED
Nuance Communications, Inc.
NUAN
| $11.6M | 3.58% |
350,000
-225,000
| -39% | -$7.47M |
|
|
12
Quest Diagnostics
DGX
$20.3B
| $11.4M | 3.53% |
100,000
-175,000
| -64% | -$20M |
|
13
ICU Medical
ICUI
$3.15B
| $11.1M | 3.44% |
61,000
-17,000
| -22% | -$3.11M |
|
|
14
Plexus
PLXS
$3.7B
| $10.2M | 3.16% |
145,000
+79,000
| +120% | +$5.58M |
|
15
Phreesia
PHR
$1.88B
| $9.64M | 2.97% |
300,000
-100,000
| -25% | -$3.21M |
|
16
RadNet
RDNT
$5.52B
| $9.59M | 2.96% |
625,000
-75,000
| -11% | -$1.15M |
|
|
17
Bio-Rad Laboratories Class A
BIO
$8.06B
| $7.73M | 2.38% |
15,000
-15,000
| -50% | -$7.73M |
|
|
OPTN
18
DELISTED
OptiNose
OPTN
| $7.22M | 2.22% |
1,850,000
+325,000
| +21% | +$1.27M |
|
|
STRM
19
DELISTED
Streamline Health Solutions
STRM
| $6.72M | 2.07% |
4,305,882
| – | – |
|
|
20
AdaptHealth
AHCO
$1.28B
| $6.65M | 2.05% |
+305,000
| New | +$6.65M |
|
21
SI-BONE Inc
SIBN
$719M
| $5.81M | 1.79% |
245,000
+139,800
| +133% | +$3.32M |
|
|
22
Turning Point Brands
TPB
$1.79B
| $5.72M | 1.76% |
+205,000
| New | +$5.72M |
|
|
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.08M | 1.56% |
900,000
-100,000
| -10% | -$564K |
|
24
Edwards Lifesciences
EW
$47.8B
| $3.99M | 1.23% |
+50,000
| New | +$3.99M |
|
|
MSON
25
DELISTED
Misonix Inc
MSON
| $3.52M | 1.08% |
300,000
-22,041
| -7% | -$259K |
|